Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Chemicals that cause cancer can’t be accurately studied

Josh Herigon, MPH
Conditions
July 1, 2010
Share
Tweet
Share

Nicholas Kristof in the New York Times writes about a new report from the President’s Cancer Panel calling attention to the role common chemicals may play in the development of cancer.

The overarching message is that we should be exercising much more caution in our trust of chemicals.

I am not familiar with the nuances of regulatory policies for chemicals, but (as Kristof points out) the “existing regulatory presumption [is] that chemicals are safe unless strong evidence emerges to the contrary.”  This approach seems insane to me.

We don’t approach the regulation of drugs this way, why are other chemicals different?  Unfortunately, changing this attitude is going to be nearly impossible given the heavy influence of chemical company lobbyists.

As important as I think the message of Kristof’s article is, I’m actually linking to this story to highlight an epidemiological problem inherent in almost any medical research attempting to link a chemical and cancer.  All such studies are observational, not experimental.

Ethically, we can’t randomize people to ingest what we think may be toxic chemicals.  Additionally, the development of cancer is slow.  Even if we ignored the ethical concerns, participants would need to be followed for decades.  Such follow-up is expensive and frequently suboptimal (participants are often “lost” when they move or simply drop-out of the study for various reasons which can bias results).

Fortunately, case-control studies were designed to overcome these very problems.  The drawback to case-control studies is that it’s difficult to measure a person’s exposure to a given chemical.  It’s generally impossible to measure it directly and asking somebody if they used a product years ago is obviously not very accurate.

Research has had success in linking some chemicals to specific diseases.  Such success has been largely limited to instances of occupational exposure.  Why?  Simply because it is easy to measure somebody’s exposure to a chemical if it happens in the work place.  Employment records can pinpoint when I person worked in a specific position and by re-creating their working conditions you can measure how much daily exposure they received.  Multiply this by the amount of time they worked there and you can easily create a relatively accurate picture of their exposure.  These studies have also been successful because workers generally receive huge doses of these chemicals and manifest severe symptoms much more quickly than the general public which may have a tiny fraction of the exposure.

This report from the President’s Cancer Panel and Kristof’s subsequent op-ed are likely to engender what may become a vitriolic debate about chemicals and their health consequences.  Undoubtedly, chemical proponents will point out that the research linking chemicals and cancer has methodological problems.  They will not be incorrect in this criticism.  When deciding for yourself, realize there are some inherent problems in trying to establish a direct, clear-cut, causal link between a given chemical and its possible impact on human health.

We can’t do a randomized clinical trial injecting one group with BPA to see if they develop cancer.  Also realize that we didn’t have to do a randomized clinical trial of smoking to establish its link to lung cancer.  As more researchers tackle this challenging problem, more evidence will emerge and recommendations will be revised.

In the meantime, I will be trusting the advice of some accomplished doctors and not that of big chemical companies.

Josh Herigon is a medical student who blogs a Number Needed to Treat.

Submit a guest post and be heard.

ADVERTISEMENT

Prev

Customer service needs to be a priority in health care

July 1, 2010 Kevin 73
…
Next

Op-ed: Paying patients to stay healthy widens the wealth gap

July 2, 2010 Kevin 0
…

Tagged as: Medications, Oncology/Hematology

Post navigation

< Previous Post
Customer service needs to be a priority in health care
Next Post >
Op-ed: Paying patients to stay healthy widens the wealth gap

ADVERTISEMENT

More by Josh Herigon, MPH

  • a desk with keyboard and ipad with the kevinmd logo

    Did the NEJM publish a bad study about checklists?

    Josh Herigon, MPH
  • a desk with keyboard and ipad with the kevinmd logo

    The threat of technology to proper patient care

    Josh Herigon, MPH
  • a desk with keyboard and ipad with the kevinmd logo

    How social media will merge with electronic medical records

    Josh Herigon, MPH

More in Conditions

  • Coconut oil’s role in Alzheimer’s and depression

    Marc Arginteanu, MD
  • Ancient health secrets for modern life

    Larry Kaskel, MD
  • How the internet broke the doctor-parent trust

    Wendy L. Hunter, MD
  • Mpox isn’t over: A silent epidemic is growing

    Melvin Sanicas, MD
  • How your family system secretly shapes your health

    Su Yeong Kim, PhD
  • The human case for preserving the nipple after mastectomy

    Thomas Amburn, MD
  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • From nurse practitioner to leader in quality improvement [PODCAST]

      The Podcast by KevinMD | Podcast
    • The crushing bureaucracy that’s driving independent physicians to extinction

      Scott Tzorfas, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
  • Recent Posts

    • Healing from medical training by learning to trust your body again [PODCAST]

      The Podcast by KevinMD | Podcast
    • How tragedy shaped a medical career

      Ronald L. Lindsay, MD | Physician
    • A doctor’s guide to preparing for your death

      Joseph Pepe, MD | Physician
    • Coconut oil’s role in Alzheimer’s and depression

      Marc Arginteanu, MD | Conditions
    • How policy and stigma block addiction treatment

      Mariana Ndrio, MD | Physician
    • Unused IV catheters cost U.S. hospitals billions

      Piyush Pillarisetti | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The human case for preserving the nipple after mastectomy

      Thomas Amburn, MD | Conditions
    • Nuclear verdicts and rising costs: How inflation is reshaping medical malpractice claims

      Robert E. White, Jr. & The Doctors Company | Policy
    • How new loan caps could destroy diversity in medical education

      Caleb Andrus-Gazyeva | Policy
    • IMGs are the future of U.S. primary care

      Adam Brandon Bondoc, MD | Physician
    • From nurse practitioner to leader in quality improvement [PODCAST]

      The Podcast by KevinMD | Podcast
    • The crushing bureaucracy that’s driving independent physicians to extinction

      Scott Tzorfas, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
  • Recent Posts

    • Healing from medical training by learning to trust your body again [PODCAST]

      The Podcast by KevinMD | Podcast
    • How tragedy shaped a medical career

      Ronald L. Lindsay, MD | Physician
    • A doctor’s guide to preparing for your death

      Joseph Pepe, MD | Physician
    • Coconut oil’s role in Alzheimer’s and depression

      Marc Arginteanu, MD | Conditions
    • How policy and stigma block addiction treatment

      Mariana Ndrio, MD | Physician
    • Unused IV catheters cost U.S. hospitals billions

      Piyush Pillarisetti | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Chemicals that cause cancer can’t be accurately studied
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...